At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 160 enrolled
Drug / intervention
Parecoxib +1 moredrug
Likely dose
Parecoxib 40 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Can Preemptive Analgesia With Parecoxib Reduce Post-operative Ipsilateral Shoulder Pain? A Double-blinded, Randomized, Placebo-controlled Trial.
In Brief
A Phase 2 clinical trial evaluating Parecoxib and Control for Shoulder Pain and Post-operative Pain. Completed, enrolled 160 participants across 2 sites.
Detailed Summary
The purpose of this study is to compare the efficacy of parecoxib with placebo on the incidence and severity of postthoracotomy shoulder pain, the amount of analgesic requirement for relieving severity of postthoracotomy shoulder pain and adverse events associated with treatment.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsShoulder Pain, Post-operative Pain
CountriesThailand
Collaborators--
Timeline
Phase 2CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartFeb 2011
First PostedFeb 2011
Primary CompletionOct 2015
Study CompletionJan 2016
TodayJul 2026
First PostedFeb 3, 2011
Enrollment StartFeb 1, 2011
Primary CompletionOct 1, 2015
Study CompletionJan 1, 2016
TodayJul 2, 2026
Enrollment to primary: 4.7 yearsPosted 15.4 years ago
Interventions
Parecoxibdrug
Parecoxib 40 mg intravenous before surgery and every 12 hours for two days.
Controlother
NSS 2 ml intravenous before surgery and every 12 hours for two days.